Mo-99 breakthrough made at Canadian lab
From medicalphysicsweb.org, 1 December 2014
The first commercial shipment of medical isotopes produced using a new particle-accelerator-based technique has been made by scientists at the Canadian Light Source (CLS). Molybdenum-99 (Mo-99) decays to create technetium-99m (Tc-99m), which is used to tag radiopharmaceuticals and plays a unique and vital role in medical imaging. Unlike nuclear reactors, which currently make most of the world's Mo-99, the system is small enough to be deployed within a large hospital and could thereby improve the supply of the short-lived isotopes. Read more >>
ctanguy, 2014-12-01 00:00:00
